Hangzhou Tigermed Consulting Co., Ltd
300347
Classement en actions
#3217
Hangzhou Tigermed Consulting Co., Ltd, together with its subsidiaries, provides... Hangzhou Tigermed Consulting Co., Ltd, together with its subsidiaries, provides contract research organization services in the People’s Republic of China and internationally. The company offers clinical trial operation services, such as clinical pharmacology, registration and regulatory affairs, scientific affairs, medical translation, pharmacovigilance, real-world research, third-party auditing and training, etc. for innovative drugs, generic drugs, and medical devices, as well as supporting services directly related to clinical trials, including clinical operation, clinical trials, and clinical trials management. It also provides clinical trial related and laboratory services in the drug development process comprising data management and statistical analysis, clinical trial site management, subject recruitment, medical imaging, and laboratory services. In addition, the company offers preclinical development services, including medicinal chemistry, compound screening, DMPK, safety and toxicology, bioanalytical, and formulation research and development services; and clinical development services, such as medical writing, clinical monitoring, regulatory affairs, data management and statistical analysis, decentralized clinical trials, clinical development strategy, site management, medical device/in vitro diagnostics, multi-region clinical trial, and vaccine clinical trial services. Further, it provides medical imaging, pharmacovigilance, medical translation, quality assurance, GMP and medical device consulting, central laboratories, functional services, recruitment management, EDC cloud-based system, and remote follow-up center services; and post-marketing clinical research solutions, such as site identification and selection, central monitoring, project team management, vendor management, and SAS project management services. Hangzhou Tigermed Consulting Co., Ltd was incorporated in 2004 and is headquartered in Hangzhou, the People’s Republic of China.
Prix de l'action
$7.44
Capitalisation boursière
$5.49B
Changement (1 jour)
-2.99%
Changement (1 an)
-0.42%
Pays
CN
Échange Hangzhou Tigermed Consulting Co., Ltd (300347)
Catégorie
Healthcare
Marge opérationnelle de Hangzhou Tigermed Consulting Co., Ltd (300347)
Marge opérationnelle au October 2026 TTM : 16.39%
Selon les derniers rapports financiers et le cours de l'action de Hangzhou Tigermed Consulting Co., Ltd, la marge opérationnelle actuelle (TTM) est de 16.39%. À la fin de 2024, elle était de 10.06%.
Historique de la marge opérationnelle pour Hangzhou Tigermed Consulting Co., Ltd de 2009 à 2026
Marge opérationnelle à la fin de chaque année
| Année | Marge opérationnelle | Changez |
|---|---|---|
| 2026 (TTM) | 16.39% | 10.97% |
| 2025 | 14.77% | 46.82% |
| 2024 | 10.06% | -70.13% |
| 2023 | 33.68% | -7.60% |
| 2022 | 36.45% | -48.60% |
| 2021 | 70.91% | 1.85% |
| 2020 | 69.62% | 79.94% |
| 2019 | 38.69% | 49.38% |
| 2018 | 25.90% | 4.82% |
| 2017 | 24.71% | 45.95% |
| 2016 | 16.93% | -24.18% |
| 2015 | 22.33% | -17.69% |
| 2014 | 27.13% | -10.55% |
| 2013 | 30.33% | 15.59% |
| 2012 | 26.24% | -7.90% |
| 2011 | 28.49% | 1.35% |
| 2010 | 28.11% | 146.80% |
| 2009 | 11.39% | 0.00% |
Marge opérationnelle pour des entreprises similaires ou concurrentes
| Entreprise | Marge opérationnelle | Différence de Marge Opérationnelle | Pays |
|---|---|---|---|
| 38.59% | -97.65% |
US
|
|
| -149.01% | -109.09% |
US
|
|
| 25.57% | -98.44% |
AU
|
|
| 31.23% | -98.09% |
BE
|
|
| 28.81% | -98.24% |
NL
|
Qu'est-ce que la Marge opérationnelle d'une entreprise ?
La Marge opérationnelle est un indicateur clé pour évaluer la rentabilité d'une entreprise. Une marge d'exploitation plus élevée est généralement préférable car elle montre qu'une entreprise peut vendre ses produits ou services bien au-dessus de leurs coûts de production. Elle se calcule en divisant les bénéfices par le chiffre d'affaires.